EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma

Melanoma is the most biologically aggressive skin cancer of well established constitutive and induced resistance to pharmacological treatment. Despite the recent progresses in immunotherapies, many advanced metastatic melanoma patients still face a significant mortality risk. The aggressive nature o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Capone, Emily, Giansanti, Francesco, Ponziani, Sara, Lamolinara, Alessia, Iezzi, Manuela, Cimini, Annamaria, Angelucci, Francesco, Sorda, Rossana La, Laurenzi, Vincenzo De, Natali, Pier Giorgio, Ippoliti, Rodolfo, Iacobelli, Stefano, Sala, Gianluca
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5707031/
https://ncbi.nlm.nih.gov/pubmed/29221137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20728
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados